Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-κB activations

Phytotherapy Research

Volumn 24, Issue 4, 2010, Pages 577-582

  Shin, Hye Kyoung ^a,b   Kim, Jin ^c   Lee, Eun Ju ^d   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Ewha Womans University   (South Korea)

^c Yonsei University College of Dentistry   (South Korea)

^d Daejeon Health Sciences College   (South Korea)

Author keywords

Curcumin; MAP kinase; Matrix metalloproteinase; Motility; NF B; Oral squamous cell carcinoma; Urokinase type plasminogen activator

Indexed keywords

CURCUMIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CURCUMIN; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NF-KAPPA B; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 77951538861     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2989     Document Type: Article

References (33)

1. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. 2004. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling. Int J Cancer 111: 679-692. (Pubitemid 39062889)
2. Aguirre-Ghiso JA, Kovalski K, Ossowski L. 1999. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104. (Pubitemid 30211799)
3. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L. 2001. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12: 863-879. (Pubitemid 33051984)
4. Bindhu OS, Ramadas K, Sebastian P, Pillai MR. 2006. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 28: 916-925. (Pubitemid 44497868)
5. Blasi F, Carmeliet P. 2002. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932-943.
6. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC. 2006. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 85: 220-225.
7. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. 2005. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190.
8. Goto H, Kawano K, Kobayashi I, Sakai H, Yanagisawa S. 2002. Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol 38: 549-556. (Pubitemid 34880117)
9. He C. 1996. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 106: 185-191.
10. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC. 2007. Epigallocatechin-3- gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 36: 588-593.
11. Hsu S, Singh B, Schuster G. 2004. Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncol 40: 461-473.
12. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53: 5-26.
13. Kim SH, Ahn S, Han JW, Lee HW, Lee HY, Lee YW, Kim MR, Kim KW, Kim WB, Hong S. 2004. Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials. Biochem Biophys Res Commun 315: 964-970.
14. Kwak YE, Jeon NK, Kim J, Lee EJ. 2007. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Ann N Y Acad Sci 1095: 99-112.
15. Lee EJ, Kim J, Lee SA, Kim EJ, Chun YC, Ryu MH, Yook JI. 2005. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37: 379-390.
16. Lee EJ, Whang JH, Jeon NK, Kim J. 2007. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism. Ann N Y Acad Sci 1095: 113-128. (Pubitemid 47092443)
17. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y. Han C, Chen J, Huang MT, Yang CS. 2002. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23: 1307-1313.
18. -△△CT method. Methods 25: 402-408.
19. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB. 2005. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11: 6994-7002. (Pubitemid 41428759)
20. Mignatti P, Rifkin DB. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195. (Pubitemid 23065437)
21. Mishima K, Yamada E, Masui K, Shimokawara T, Takayama K, Sugimura M, Ichijima K. 1998. Overexpression of the ERK/ MAP kinases in oral squamous cell carcinoma. Mod Pathol 11: 886-891. (Pubitemid 28440886)
22. Mishima K, Inoue K, Hayashi Y. 2002. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 38: 468-474. (Pubitemid 34756732)
23. Novak U, Cocks BG, Hamilton JA. 1991. A labile repressor acts through the NFκB-like binding sites of the human urokinase gene. Nucleic Acids Res 19: 3389-3393. (Pubitemid 21912698)
24. Nozaki S, Endo Y, Kawashiri S, Nakagawa K, Yamamoto E, Yonemura Y, Sasaki T. 1998. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. Oral Oncol 34: 58-62. (Pubitemid 28210532)
25. Pezzuto JM. 1997. Plant-derived anticancer agents. Biochem Pharmacol 53: 121-133.
26. Preissner KT, Kanse SM, May AE. 2000. Urokinase receptor: a molecular organizer in cellular communication. Curr Opin Cell Biol 12: 621-628.
27. Rhee JC, Khuri FR, Shin DM. 2004. Advances in chemoprevention of head and neck cancer. Oncologist 9: 302-311. (Pubitemid 38756878)
28. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
29. Salagami H, Kobayashi M, Chien CH, Kanegae H, Kavase M. 2007. Selective toxicity and type of cell death induced by various natural and synthetic compounds in oral squamous cell carcinoma. In Vivo 21: 311-320. (Pubitemid 46534286)
30. Su CC, Chen GW, Lin JG, Wu LT, Chung JG. 2006. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappaB /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26: 1281-1288.
31. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A, Ogawa H. 1994. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 54: 4653-4659. (Pubitemid 24276489)
32. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. 1993. Head and neck cancer. N Engl J Med 328: 184-194.
33. Yook JI, Lee SA, Chun YC, Huh J, Cha IH, Kim J. 2004. The myoepithelial cell differentiation of mucoepidermoid carcinoma in a collagen gel-based coculture model. J Oral Pathol Med 33: 237-242. (Pubitemid 38478511)